Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| SABS (SAB Biotherapeutics, Inc.) | -9.63% | 84.70% | 53.20% | -19.29% | NA | NA | NA | … | … |
Data as of 06/05/2026, Common starting date is 02/09/2021
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| SABS (SAB Biotherapeutics, Inc.) | 02/09/2021 | 06/05/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | -6.11 | 84.70 | 53.20 | -19.29 | NA | NA | NA | … | … | -9.63 | -0.26 | 5,871.43 | 16.97 | -92.45 | -23.05 |
| Sharpe Ratio | NA | 1.01 | 0.16 | -0.09 | NA | NA | NA | … | … | -0.38 | -0.03 | 12.78 | 0.11 | -0.78 | -0.39 |
| Standard Deviation(%) | NA | 81.49 | 314.45 | 254.57 | NA | NA | NA | … | … | 62.69 | 118.63 | 474.58 | 115.80 | 120.10 | 65.85 |
| Draw Down(%) | NA | 33.80 | 93.03 | 99.38 | NA | NA | NA | … | … | 26.80 | 74.54 | 68.43 | 57.11 | 93.61 | 30.52 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/05/2026, Common starting date is 02/09/2021
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| SABS (SAB Biotherapeutics, Inc.) |
-35.68%
May 2021 – May 2024 |
-18.35%
May 2021 – May 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| SABS (SAB Biotherapeutics, Inc.) |
105.71%
Mar 2023 – Mar 2026 |
-17.16%
Mar 2021 – Mar 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart